CA2110942A1 - Imidazo¬1,5-a|quinoxalines - Google Patents
Imidazo¬1,5-a|quinoxalinesInfo
- Publication number
- CA2110942A1 CA2110942A1 CA002110942A CA2110942A CA2110942A1 CA 2110942 A1 CA2110942 A1 CA 2110942A1 CA 002110942 A CA002110942 A CA 002110942A CA 2110942 A CA2110942 A CA 2110942A CA 2110942 A1 CA2110942 A1 CA 2110942A1
- Authority
- CA
- Canada
- Prior art keywords
- quinoxaline
- dihydro
- carbonyl
- imidazo
- oxadiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71593091A | 1991-06-14 | 1991-06-14 | |
US84365092A | 1992-02-28 | 1992-02-28 | |
US843,650 | 1992-02-28 | ||
US715,930 | 1992-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2110942A1 true CA2110942A1 (fr) | 1992-12-23 |
Family
ID=27109441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002110942A Abandoned CA2110942A1 (fr) | 1991-06-14 | 1992-06-01 | Imidazo¬1,5-a|quinoxalines |
Country Status (8)
Country | Link |
---|---|
US (3) | US5541324A (fr) |
EP (1) | EP0590022A1 (fr) |
JP (1) | JP3147902B2 (fr) |
KR (1) | KR100207360B1 (fr) |
AU (1) | AU657986B2 (fr) |
CA (1) | CA2110942A1 (fr) |
MX (1) | MX9202838A (fr) |
WO (1) | WO1992022552A1 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0590022A1 (fr) * | 1991-06-14 | 1994-04-06 | PHARMACIA & UPJOHN COMPANY | IMIDAZO 1,5-a]QUINOXALINES |
CH684644A5 (de) * | 1992-07-13 | 1994-11-15 | Eprova Ag | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. |
FR2704547B1 (fr) * | 1993-04-30 | 1995-06-09 | Adir | Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
EP0729469B1 (fr) * | 1993-11-19 | 1998-09-23 | PHARMACIA & UPJOHN COMPANY | IMIDAZO [1,5-a]QUINOLINES POUR LE TRAITEMENT DE L'ANXIETE ET DES TROUBLES DU SOMMEIL |
US5536718A (en) * | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
US5792766A (en) * | 1996-03-13 | 1998-08-11 | Neurogen Corporation | Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands |
US6063774A (en) * | 1996-12-16 | 2000-05-16 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
HRP980375A2 (en) | 1997-07-03 | 1999-04-30 | Argyrios Georgios Arvanitis | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
US20040180898A1 (en) * | 2003-03-03 | 2004-09-16 | Bang-Chi Chen | Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazines |
TW200817400A (en) * | 2006-05-30 | 2008-04-16 | Elbion Ag | Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
PE20080344A1 (es) | 2006-06-27 | 2008-06-09 | Sanofi Aventis | Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1 |
PE20080212A1 (es) * | 2006-06-27 | 2008-04-25 | Sanofi Aventis | Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1) |
FR2902790A1 (fr) * | 2006-06-27 | 2007-12-28 | Sanofi Aventis Sa | Derives d'urees de piperidine ou pyrrolidine,leur preparation et leur application en therapeutique |
WO2008154442A1 (fr) * | 2007-06-08 | 2008-12-18 | Helicon Therapeutics, Inc. | Dérivés d'urée de pyrazoloquinoline thérapeutiques |
CA2706866A1 (fr) | 2007-11-30 | 2009-06-04 | Biotie Therapies Gmbh | Imidazo[1,5-a]pyrazines fusionnees avec aryle et heteroaryle en tant qu'inhibiteurs de phosphodiesterase 10 |
AU2008329072A1 (en) * | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10 |
DK2299821T3 (en) | 2008-06-10 | 2016-02-15 | Abbvie Inc | Tricyclic compounds |
NZ599938A (en) | 2009-12-01 | 2014-08-29 | Abbvie Inc | Novel tricyclic compounds |
RS56317B1 (sr) | 2009-12-01 | 2017-12-29 | Abbvie Inc | Nova triciklična jedinjenja |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
UA117347C2 (uk) | 2012-06-13 | 2018-07-25 | Інсайт Холдинґс Корпорейшн | Заміщені трициклічні сполуки як інгібітори fgfr |
WO2014026125A1 (fr) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Dérivés de pyrazine en tant qu'inhibiteurs de fgfr |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
CN105263931B (zh) | 2013-04-19 | 2019-01-25 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
WO2016134294A1 (fr) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
UA121669C2 (uk) | 2015-02-20 | 2020-07-10 | Інсайт Корпорейшн | Біциклічні гетероцикли як інгібітори fgfr |
US11780848B2 (en) | 2015-10-16 | 2023-10-10 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof |
SG10201913986YA (en) | 2015-10-16 | 2020-03-30 | Abbvie Inc | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
SG11202010636VA (en) | 2018-05-04 | 2020-11-27 | Incyte Corp | Solid forms of an fgfr inhibitor and processes for preparing the same |
MA52493A (fr) | 2018-05-04 | 2021-03-10 | Incyte Corp | Sels d'un inhibiteur de fgfr |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
WO2021007269A1 (fr) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
PE20221085A1 (es) | 2019-10-14 | 2022-07-05 | Incyte Corp | Heterociclos biciclicos como inhibidores de fgfr |
WO2021076728A1 (fr) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
WO2021113479A1 (fr) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Hétérocycles tricycliques en tant qu'inhibiteurs de fgfr |
CN115151539A (zh) | 2019-12-04 | 2022-10-04 | 因赛特公司 | Fgfr抑制剂的衍生物 |
CA3220274A1 (fr) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1551166A (en) * | 1976-03-22 | 1979-08-22 | Squibb & Sons Inc | Pyrazolo (1,5-a)quinoxaline-3-carboxylic acid and derivatives thereof |
SE439308B (sv) * | 1978-08-02 | 1985-06-10 | Roussel Uclaf | Imidazo(1,2-a)kinoxaliner och farmaceutiska kompositioner derav |
FR2448541A1 (fr) * | 1979-02-09 | 1980-09-05 | Roussel Uclaf | Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
DK476885D0 (da) * | 1985-10-17 | 1985-10-17 | Ferrosan As | Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf |
DK155524C (da) * | 1987-03-18 | 1989-09-11 | Ferrosan As | Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse |
DK160876C (da) * | 1987-12-08 | 1991-10-14 | Novo Nordisk As | Imidazoquinoxalinforbindelser, fremgangsmaade til deres fremstilling, anvendelse af forbindelserne og farmaceutiske praeparater, hvori forbindelserne indgaar |
IL90315A0 (en) * | 1988-06-01 | 1989-12-15 | Ferrosan As | Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them |
DK161148C (da) * | 1988-06-14 | 1991-11-18 | Novo Nordisk As | Imidazoquinoxalinforbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende forbindelserne |
DK626288D0 (da) * | 1988-11-10 | 1988-11-10 | Ferrosan As | Kemisk proces til fremstilling af imidazoquinoxaliner og mellemprodukter til brug i processen |
EP0590022A1 (fr) * | 1991-06-14 | 1994-04-06 | PHARMACIA & UPJOHN COMPANY | IMIDAZO 1,5-a]QUINOXALINES |
AU641851B1 (en) * | 1992-03-10 | 1993-09-30 | Neurogen Corporation | Certain imidazoquinoxalines; a new class of GABA brain receptor ligands |
-
1992
- 1992-06-01 EP EP92913318A patent/EP0590022A1/fr not_active Withdrawn
- 1992-06-01 WO PCT/US1992/004434 patent/WO1992022552A1/fr not_active Application Discontinuation
- 1992-06-01 AU AU21704/92A patent/AU657986B2/en not_active Ceased
- 1992-06-01 JP JP50087793A patent/JP3147902B2/ja not_active Expired - Fee Related
- 1992-06-01 KR KR1019930703865A patent/KR100207360B1/ko not_active IP Right Cessation
- 1992-06-01 CA CA002110942A patent/CA2110942A1/fr not_active Abandoned
- 1992-06-12 MX MX9202838A patent/MX9202838A/es active IP Right Grant
-
1993
- 1993-12-13 US US08/166,037 patent/US5541324A/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/466,959 patent/US5574038A/en not_active Expired - Fee Related
- 1995-06-06 US US08/469,719 patent/US5668282A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2170492A (en) | 1993-01-12 |
US5668282A (en) | 1997-09-16 |
WO1992022552A1 (fr) | 1992-12-23 |
AU657986B2 (en) | 1995-03-30 |
KR100207360B1 (ko) | 1999-07-15 |
EP0590022A1 (fr) | 1994-04-06 |
JPH06508366A (ja) | 1994-09-22 |
MX9202838A (es) | 1993-02-01 |
US5574038A (en) | 1996-11-12 |
JP3147902B2 (ja) | 2001-03-19 |
US5541324A (en) | 1996-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2110942A1 (fr) | Imidazo¬1,5-a|quinoxalines | |
CA1252462A (fr) | Derives d'imidazodiazepine | |
Tully et al. | 2-(Oxadiazolyl)-and 2-(thiazolyl) imidazo [1, 2-a] pyrimidines as agonists and inverse agonists at benzodiazepine receptors | |
US7153848B2 (en) | Inhibitors of HCV replication | |
JP4056015B2 (ja) | PDE−5抑制活性を有する5,7−ジアミノピラゾロ[4,3−d]ピリミジン | |
US5972951A (en) | Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists | |
AU2007266840B2 (en) | Pyrrolo[1,2-A]pyrazin-1(2H)-one and pyrrolo[1,2-D][1,2,4]triazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose)polymerase(PARP) | |
JP2690282B2 (ja) | イミダゾジアゼピン | |
CZ185092A3 (en) | Imidazodiazepines | |
WO2001077111A1 (fr) | Derives de pyrazolo-triazine utilises en tant que ligands pour des recepteurs gaba | |
WO2012007006A1 (fr) | Dérivés de triazolo- et de pyrazoloquinazoline en tant qu'inhibiteurs d'enzyme pde10a | |
FI92203C (fi) | Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi | |
US6297235B1 (en) | Triazolopyridazine derivatives for treating anxiety and enhancing cognition | |
EP1242423A1 (fr) | 1,2,3-TRIAZOLO 1,5-a]QUINAZOLINES SUBSTITUE NOOTROPE | |
AU708843B2 (en) | Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles as antipsychotic agents | |
EP0491814B1 (fr) | Derives d'imidazoquinazoline tetracycliques, leur preparation et compositions pharmaceutiques | |
US4761412A (en) | Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses | |
Ashwood et al. | Synthesis of 5, 6-dihydro-4 H-imidazo [1, 5-a][4, 1] benzoxazepin-6-ones and their transformation into 5, 6-dihydro-4 H-imidazo [1, 5-a][1, 4] benzodiazepin-6-ones | |
RU2169148C2 (ru) | АНЕЛЛИРОВАННЫЕ β--КАРБОЛИНЫ | |
IE59495B1 (en) | Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions | |
HRP950125A2 (en) | Imidazodiazepines | |
MXPA97009450A (en) | Piridiniminil-1,2-benzoisoxazoles and -benzoisotiazoles as agents antipsicoti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |